Crunching the numbers for NVAX... Refresh in a moment for the full analysis.
NOVAVAX INC (NVAX)
Healthcare
healthy
$8.12
Updated: 2026-04-12
62
TradeApes Score
add
Financial Strength
70
Healthy
Operating Trend
65
Healthy
Valuation
50
Mixed
Capital Allocation
55
Mixed
Risk
70
Healthy
Key Findings
+
Net cash position — more cash on hand than total debt
−
Large FCF burn — cash consumption exceeds 10% of revenue
See the full analysis
Quarterly financials, DCF valuation model, Watchlist, and Stock Screener.
Create Free Account
Scores and valuations are model outputs, not investment advice. TradeApes does not provide financial, tax, or investment advice.